Caregiver adverse childhood experiences were related to pediatric health outcomes, such as antibiotic prescribing and time to first infection-related clinical encounter.
ORLYNVAH™ is a novel oral penem antibiotic for the treatment of uUTI. ORLYNVAH™ possesses potent activity against species of Enterobacterales including those that encode extended spectrum ...